Of note was the predominance of PASD1-specific T-cell responses in 8 of 26 AML patients, perhaps reflecting the presence of four HLA-A2 restricted pMHC-PASD1 on the array, rather than the single pMHC-epitopes detecting most other tumour antigens. Here, PASD1 is linked to neoplasm.